Abstract
Point of care (POC) diagnostics are often hailed as having the potential to transform tuberculosis (TB) control efforts. However, POC testing is better conceptualized as a system of diagnosis and treatment, not simply a test that can provide rapid, deployable results. Economic evaluations may help decision makers allocate scarce resources for TB control, but evaluations of POC testing face unique challenges that include evaluating the full diagnostic system, incorporating implementation costs, translating diagnostic results into health and accounting for downstream treatment costs. For economic evaluations to reach their full potential as decision-making tools for POC testing in TB, these challenges must be understood and addressed.
Original language | English (US) |
---|---|
Pages (from-to) | 313-325 |
Number of pages | 13 |
Journal | Expert Review of Pharmacoeconomics and Outcomes Research |
Volume | 13 |
Issue number | 3 |
DOIs | |
State | Published - 2013 |
Keywords
- cost-benefit analysis
- costs and cost analysis
- diagnostic techniques and procedures
- economic models
- point of care systems
- tuberculosis
ASJC Scopus subject areas
- Health Policy
- Pharmacology (medical)